ELB139
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ELB139, covering 2006-09-29 to 2006-09-29. Get the full timeline:
Most recent: Clinical Trial Update: ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment [Phase 2]